The Clorox Company [NYSE: CLX] loss -0.07% on the last trading session, reaching $212.23 price per share at the time.
The Clorox Company represents 126.39 million in outstanding shares, while the company has a total market value of $26.62 billion with the latest information. CLX stock price has been found in the range of $210.08 to $213.51.
If compared to the average trading volume of 1.44M shares, CLX reached a trading volume of 1145824 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about The Clorox Company [CLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLX shares is $225.31 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLX stock is a recommendation set at 2.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
DA Davidson have made an estimate for The Clorox Company shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 30, 2020. While these analysts kept the previous recommendation, Credit Suisse raised their target price from $169 to $172. The new note on the price target was released on March 19, 2020, representing the official price target for The Clorox Company stock. Previously, the target price had yet another raise from $153 to $185, while JP Morgan kept a Overweight rating on CLX stock.
The Average True Range (ATR) for The Clorox Company is set at 5.20, with the Price to Sales ratio for CLX stock in the period of the last 12 months amounting to 3.96. The Price to Book ratio for the last quarter was 29.56, with the Price to Cash per share for the same quarter was set at 6.94. Price to Free Cash Flow for CLX in the course of the last twelve months was 35.07 with Quick ratio for the last quarter at 1.10.
Trading performance analysis for CLX stock
The Clorox Company [CLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.35. With this latest performance, CLX shares dropped by -4.89% in over the last four-week period, additionally plugging by 28.11% over the last 6 months – not to mention a rise of 40.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLX stock in for the last two-week period is set at 44.17, with the RSI for the last a single of trading hit 46.09, and the three-weeks RSI is set at 44.73 for The Clorox Company [CLX]. The present Moving Average for the last 50 days of trading for this stock 223.33, while it was recorded at 209.63 for the last single week of trading, and 192.30 for the last 200 days.
The Clorox Company [CLX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and The Clorox Company [CLX] shares currently have an operating margin of +18.82 and a Gross Margin at +45.44. The Clorox Company’s Net Margin is presently recorded at +13.97.
Return on Total Capital for CLX is now 34.72, given the latest momentum, and Return on Invested Capital for the company is 27.52. Return on Equity for this stock inclined to 128.02, with Return on Assets sitting at 16.58. When it comes to the capital structure of this company, The Clorox Company [CLX] has a Total Debt to Total Equity ratio set at 345.37. Additionally, CLX Total Debt to Total Capital is recorded at 77.55, with Total Debt to Total Assets ending up at 50.47. Long-Term Debt to Equity for the company is recorded at 338.11, with the Long-Term Debt to Total Capital now at 75.91.
Reflecting on the efficiency of the workforce at the company, The Clorox Company [CLX] managed to generate an average of $106,705 per employee. Receivables Turnover for the company is 10.51 with a Total Asset Turnover recorded at a value of 1.19.The Clorox Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.40.
The Clorox Company [CLX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, The Clorox Company posted 1.59/share EPS, while the average EPS was predicted by analysts to be reported at 1.54/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for The Clorox Company go to 4.57%.
An analysis of insider ownership at The Clorox Company [CLX]
There are presently around $21,408 million, or 81.80% of CLX stock, in the hands of institutional investors. The top three institutional holders of CLX stocks are: VANGUARD GROUP INC with ownership of 15,569,472, which is approximately -2.415% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 11,324,739 shares of the stock with an approximate value of $2.4 billion in CLX stocks shares; and STATE STREET CORP, currently with $1.59 billion in CLX stock with ownership of nearly -9.592% of the company’s market capitalization.
584 institutional holders increased their position in The Clorox Company [NYSE:CLX] by around 10,208,139 shares. Additionally, 505 investors decreased positions by around 9,998,172 shares, while 188 investors held positions by with 80,664,053 shares. The mentioned changes placed institutional holdings at 100,870,364 shares, according to the latest SEC report filing. CLX stock had 173 new institutional investments in for a total of 913,417 shares, while 78 institutional investors sold positions of 2,104,548 shares during the same period.